Figures & data
Figure 1 Flow chart for the trial.
Table 1 Baseline characteristics of the subjects by mifepristone group
Table 2 Motives for emergency contraception and previous use of birth control methods by mifepristone group
Table 3 Main results by mifepristone group
Table 4 The number of pregnancies in the 5 mg and 10 mg group according to the number of days after unprotected sexual intercourse that mifepristone administration occurred
Table 5 The number of pregnancies in the 5 mg and 10 mg groups according to the number of days after unprotected sexual intercourse that mifepristone administration occurred
Table 6 The failure rate (ie, number of pregnancies) in the 5 mg and 10 mg mifepristone group according to body weight
Table 7 Mifepristone-associated side effects in the first week posttreatment
Table 8 Subjects in the 5 mg and 10 mg mifepristone group who experienced menstruation earlier than expected
Table 9 Subjects who experienced a delay (days) in the onset of menstruation between treatment groups